Myovant Sciences Ltd.
MYOVDelisted Mar 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679082
Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Myovant Sciences Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 104 | 108 | +4 |
| Shares | 30.3M | 32.4M | +2.06M (+6.8%) |
| Value | $623.2M | $736.6M | +$113.3M (+18.2%) |
New holders (23)
Institutions that held Myovant Sciences Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (19)
Institutions that held Myovant Sciences Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Tri Locum Partners LP | 321,101 | $6.61M |
| Opaleye Management Inc. | 249,800 | $5.14M |
| California Public Employees Retirement System | 88,200 | $1.81M |
| Two Sigma Investments, LP | 36,997 | $761.0K |
| Two Sigma Advisers, LP | 34,700 | $714.0K |
| QS Investors, LLC | 28,000 | $576.0K |
| Paloma Partners Management Co | 18,131 | $373.0K |
| Federation des caisses Desjardins du Quebec | 14,078 | $289.9K |
| Susquehanna Fundamental Investments, LLC | 12,100 | $249.0K |
| Trilogy Capital Inc. | 10,979 | $226.0K |
| Qube Research & Technologies Ltd | 10,255 | $211.0K |
| Tower Research Capital LLC (TRC) | 3,567 | $73.0K |
| Walleye Trading LLC | 2,048 | $42.0K |
| Quantbot Technologies LP | 1,400 | $28.0K |
| Sowell Financial Services LLC | 1,349 | $26.0K |
| Bank of Montreal | 1,170 | $21.0K |
| Total Clarity Wealth Management, Inc. | 350 | $7.00K |
| Institutional & Family Asset Management, LLC | 85 | $2.00K |
| Harel Insurance Investments & Financial Services Ltd. | 4,000 | – |